Yi Xiao

机构：Beijing University of Posts and Telecommunications, Pacific Northwest National Laboratory, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing General Hospital of Nanjing Military Command, Government of the United States of America, Peking Union Medical College Hospital, Fudan University Shanghai Cancer Center, First Hospital of Lanzhou University, Chengdu University of Traditional Chinese Medicine, University of Nebraska Medical Center, Lanzhou University, Nanjing Medical University, Nanjing University · ORCID：0000-0002-1389-3106

发表论文 96 篇 · 总被引 2098 次 · h-index 24

代表论文

• Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment (2023 · Frontiers in Immunology · 被引 119)
• Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy in locally advanced rectal cancer (UNION): early outcomes of a multicenter randomized phase III trial (2024 · Annals of Oncology · 被引 115)
• Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer (2025 · Cancer Cell · 被引 51)
• Differentiated mesenchymal stem cells-derived exosomes immobilized in decellularized sciatic nerve hydrogels for peripheral nerve repair (2024 · Journal of Controlled Release · 被引 39)
• Total neoadjuvant treatment with long-course radiotherapy versus concurrent chemoradiotherapy in local advanced rectal cancer with high risk factors (TNTCRT): A multicenter, randomized, open-label, phase 3 trial. (2024 · Journal of Clinical Oncology · 被引 17)
• Nomogram using intratumoral and peritumoral radiomics for the preoperative prediction of visceral pleural invasion in clinical stage IA lung adenocarcinoma (2024 · Journal of Cardiothoracic Surgery · 被引 17)